Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib.
Seiz
Marcel
M
Department of Neurosurgery, Medical Faculty of the University of Heidelberg, Mannheim, Germany.
Nölte
Ingo
I
Pechlivanis
Ioannis
I
Freyschlag
Christian F
CF
Schmieder
Kirsten
K
Vajkoczy
Peter
P
Tuettenberg
Jochen
J
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000473:pathology* / Q000628:therapy; D000068579:Celecoxib; D016543:Central Nervous System Neoplasms / Q000556:secondary*; D002555:Cerebrospinal Fluid; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D005909:Glioblastoma / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D013534:Survival; D000077204:Temozolomide
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D011720:Pyrazoles; D013449:Sulfonamides; D003606:Dacarbazine; D000068579:Celecoxib; D000077204:Temozolomide